Mobile-health Network Solutions Class A Ordinary Shares (MNDR)

FairStock Score: 46/100 — MIXED

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

I approach this as a Graham-style exercise in protecting capital first. Mobile-health Network Solutions is a Singapore telehealth operator with the MaNaDr platform and two segments: telemedicine/other services and sale of medicine and medical devices. At the 2026-10-13 close of $1.46, the market cap is only $4.2 million, and FairStock calculations show a P/B of 0.10 and a negative P/E of -0.10. A price below book can be enticing, but the quality signals are poor: ROE is -47.59%, ROCE is -23.55%, Piotroski F-Score is 2/9, and Altman Z-Score is -1.88. Those numbers describe a business that is losing money and carries meaningful financial distress risk, even though D/E is just 0.01. The low debt is a genuine positive; the rest is not. The company has no dividend, revenue and profit growth are N/A, and the Lynch category is none because there are only 0 years of filed results, versus the 3 years needed. That absence of a track record is critical: I cannot judge pricing power, customer retention, or whether the MaNaDr platform has a durable moat. The 52-week range of $0.40 to $5.67 and beta of -0.81 tell me the shares are highly volatile and may not behave like a normal healthcare holding. FairStock Score of 46/100 is middling at best. Growth could come if telehealth adoption and medicine/device sales scale, but today the evidence shows weak economics and little history. I would want several years of clean filings and improving returns before calling this a sound value proposition.

In plain English: Mobile-health Network Solutions runs a telehealth platform called MaNaDr and sells medicine and medical devices, mainly in Singapore. The business looks weak right now: it is losing money, has a very short public reporting history, and shows signs of financial stress. At $1.46, the price looks very low compared with its book value, but that may reflect uncertainty rather than a true bargain.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data as of 2026-10-13 close · note generated 2026-10-15 · model deepseek-flash

Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer